APA (7th ed.) Citation

Henrich, M. T., Oertel, W. H., Surmeier, D. J., & Geibl, F. F. (2023). Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential. Molecular neurodegeneration, 18(1), 83-20. https://doi.org/10.1186/s13024-023-00676-7

Chicago Style (17th ed.) Citation

Henrich, Martin T., Wolfgang H. Oertel, D. James Surmeier, and Fanni F. Geibl. "Mitochondrial Dysfunction in Parkinson’s Disease – a Key Disease Hallmark with Therapeutic Potential." Molecular Neurodegeneration 18, no. 1 (2023): 83-20. https://doi.org/10.1186/s13024-023-00676-7.

MLA (9th ed.) Citation

Henrich, Martin T., et al. "Mitochondrial Dysfunction in Parkinson’s Disease – a Key Disease Hallmark with Therapeutic Potential." Molecular Neurodegeneration, vol. 18, no. 1, 2023, pp. 83-20, https://doi.org/10.1186/s13024-023-00676-7.